MCRB
Seres Therapeutics
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
MCRB fundamentals
Seres Therapeutics (MCRB) released its earnings on May 7, 2025: revenue was -- (YoY 0.00%), beat estimates; EPS was 3.76 (YoY +1492.59%), missed estimates.
Revenue / YoY
--
0.00%
EPS / YoY
3.76
+1492.59%
Report date
May 7, 2025
MCRB Earnings Call Summary for Q1,2025
- SER-155 Milestone Progress: Phase 2 protocol submission imminent; 77% BSI risk reduction in Phase 1b validates potential for allo-HSCT standard of care.
- Partnership Priority: Securing external funding critical to initiating Phase 2, with FDA-aligned design enabling accelerated path to registration.
- Financial Resilience: $58.8M cash runway to Q1 2026, with disciplined cost management and Nestlé payments supporting operations.
- Strategic Expansion: Live biotherapeutic platform targeting IBD, CAR-T, and auto-HSCT, backed by mechanistic data showing gut barrier restoration.
EPS
Revenue
Revenue & Expenses
Key Indicators
Seres Therapeutics (MCRB) key financial stats and ratios, covering profitability, financial health, and leverage.
Seres Therapeutics (MCRB)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Seres Therapeutics (MCRB)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Seres Therapeutics (MCRB)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Seres Therapeutics (MCRB) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Seres Therapeutics (MCRB) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the market’s earnings forecast for Seres Therapeutics next quarter?What factors drove the changes in Seres Therapeutics’s revenue and profit?What is the revenue and EPS growth rate for Seres Therapeutics year over year?What were the key takeaways from Seres Therapeutics’s earnings call?What does Seres Therapeutics do and what are its main business segments?Did Seres Therapeutics beat or miss consensus estimates last quarter?What guidance did Seres Therapeutics’s management provide for the next earnings period? What is Seres Therapeutics’s latest dividend and current dividend yield?